Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Zinc Resistant Starch Project

Not Applicable

Completed

Conditions: Enteropathy

Interventions: Dietary Supplement: Zinc

First Posted Date: 2013-03-15

Last Posted Date: 2018-08-02

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 20

Registration Number: NCT01811836

Locations: 🇲🇼
Project Peanut Butter Factory, Blantyre, Malawi

Pharmacokinetics and Side Effects of the mGlu5 Antagonist Fenobam in Adult Healthy Volunteers

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Fenobam
Drug: Placebo

First Posted Date: 2013-03-07

Last Posted Date: 2015-12-09

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 32

Registration Number: NCT01806415

Locations: 🇺🇸
Washington University School Of Medicine, St. Louis, Missouri, United States

Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence

Not Applicable

Active, not recruiting

Conditions: HIV

Interventions: Behavioral: Bolstered Standard of Care
Behavioral: Suubi+Adherence

First Posted Date: 2013-02-13

Last Posted Date: 2023-07-27

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 702

Registration Number: NCT01790373

Locations: 🇺🇬
International Center for Child Health and Asset Development, Masaka, Uganda
🇺🇸
Washington University in St. Louis, Saint Louis, Missouri, United States

Probiotic LGG for Prevention of Side Effects in Patients Undergoing Chemoradiation for Gastrointestinal Cancer

Phase 1

Terminated

Conditions: Gastrointestinal Neoplasms

Interventions: Drug: LGG
Drug: Placebo

First Posted Date: 2013-02-12

Last Posted Date: 2022-03-16

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 23

Registration Number: NCT01790035

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Whey Permeate Study

Not Applicable

Completed

Conditions: Malnutrition

Interventions: Dietary Supplement: Whey permeate RUSF
Dietary Supplement: Soy Protein RUSF

First Posted Date: 2013-02-12

Last Posted Date: 2019-01-17

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 2259

Registration Number: NCT01790048

Locations: 🇲🇼
Project Peanut Butter, Blantyre, Malawi

Moderate Acute Malnutrition (MAM) and Severe Acute Malnutrition (SAM) in Sierra Leone

Not Applicable

Completed

Conditions: Malnutrition

Interventions: Other: Integrated Protocol
Other: Current protocol

First Posted Date: 2013-02-07

Last Posted Date: 2020-03-26

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 1957

Registration Number: NCT01785680

Locations: 🇸🇱
Project Peanut Butter Factory - 41D Wilkinson Road, Freetown, Sierra Leone

VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Everolimus for Treating Patients With Pancreatic Neuroendocrine Tumors

Phase 1

Terminated

Conditions: Adenocarcinoma
Pancreatic Neoplasms

Interventions: Drug: X-82
Drug: Everolimus

First Posted Date: 2013-02-06

Last Posted Date: 2021-07-08

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 23

Registration Number: NCT01784861

Locations: 🇺🇸
Vanderbilt University, Nashville, Tennessee, United States
🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Esophageal Cancer Tissue Banking

Completed

Conditions: Esophageal Cancer

First Posted Date: 2013-01-31

Last Posted Date: 2022-08-09

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 311

Registration Number: NCT01780961

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Development of a PET-MR Myocardial Perfusion Examination Using Regadenoson

Phase 4

Completed

Conditions: Ischemic Heart Disease

Interventions: Drug: Regadenoson

First Posted Date: 2013-01-30

Last Posted Date: 2018-06-15

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 16

Registration Number: NCT01779869

Locations: 🇺🇸
Center for Clinical Imaging Research at Washington University School of Medicine, Saint Louis, Missouri, United States

Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor Cells

Phase 2

Terminated

Conditions: Breast Neoplasms

Interventions: Drug: Doxorubicin
Biological: Trastuzumab
Drug: Cyclophosphamide
Drug: Paclitaxel
Drug: Epirubicin
Drug: Docetaxel
Drug: Fluorouracil
Drug: Carboplatin

First Posted Date: 2013-01-29

Last Posted Date: 2022-11-01

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 7

Registration Number: NCT01779050

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy